Vestal Point Capital »

Applied Therapeutics shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Applied Therapeutics (APLT) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Applied Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Applied Therapeutics held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Applied Therapeutics by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $25M 5.4M 4.67

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Applied Therapeutics

Franklin Resources
VR Adviser
Perceptive Advisors
Henderson Group
BlackRock
Propel Bio Management
Knoll Capital Management
Vestal Point Capital
Vanguard Group
Morgan Stanley
Simplify Asset Management
Deutsche Bank Aktiengesellschaft
Tang Capital Management
Frazier Life Sciences Management
Stempoint Capital

View all funds holding Applied Therapeutics